These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9502076

  • 1. Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential.
    Zhou BS, Tsai P, Ker R, Tsai J, Ho R, Yu J, Shih J, Yen Y.
    Clin Exp Metastasis; 1998 Jan; 16(1):43-9. PubMed ID: 9502076
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
    Zhou BS, Hsu NY, Pan BC, Doroshow JH, Yen Y.
    Cancer Res; 1995 Mar 15; 55(6):1328-33. PubMed ID: 7882331
    [Abstract] [Full Text] [Related]

  • 3. Determination of deoxyribonucleoside triphosphate pool sizes in ribonucleotide reductase cDNA transfected human KB cells.
    Zhou BS, Ker R, Ho R, Yu J, Zhao YR, Shih J, Yen Y.
    Biochem Pharmacol; 1998 May 15; 55(10):1657-65. PubMed ID: 9634002
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
    Kuo ML, Hwang HS, Sosnay PR, Kunugi KA, Kinsella TJ.
    Cancer J; 2003 May 15; 9(4):277-85. PubMed ID: 12967138
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA.
    Chen S, Zhou B, He F, Yen Y.
    Antisense Nucleic Acid Drug Dev; 2000 Apr 15; 10(2):111-6. PubMed ID: 10805162
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line.
    Goan YG, Zhou B, Hu E, Mi S, Yen Y.
    Cancer Res; 1999 Sep 01; 59(17):4204-7. PubMed ID: 10485455
    [Abstract] [Full Text] [Related]

  • 7. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
    Zhou B, Liu X, Mo X, Xue L, Darwish D, Qiu W, Shih J, Hwu EB, Luh F, Yen Y.
    Cancer Res; 2003 Oct 15; 63(20):6583-94. PubMed ID: 14583450
    [Abstract] [Full Text] [Related]

  • 8. Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit.
    Jung CP, Motwani MV, Schwartz GK.
    Clin Cancer Res; 2001 Aug 15; 7(8):2527-36. PubMed ID: 11489836
    [Abstract] [Full Text] [Related]

  • 9. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
    Liu X, Zhou B, Xue L, Shih J, Tye K, Lin W, Qi C, Chu P, Un F, Wen W, Yen Y.
    Clin Cancer Res; 2006 Nov 01; 12(21):6337-44. PubMed ID: 17085643
    [Abstract] [Full Text] [Related]

  • 10. Altered expression of ribonucleotide reductase and role of M2 gene amplification in hydroxyurea-resistant hamster, mouse, rat, and human cell lines.
    Wright JA, Alam TG, McClarty GA, Tagger AY, Thelander L.
    Somat Cell Mol Genet; 1987 Mar 01; 13(2):155-65. PubMed ID: 3551113
    [Abstract] [Full Text] [Related]

  • 11. DNA repair initiation induces expression of ribonucleotide reductase in human chronic lymphocytic leukemia cells.
    Sandoval MR, Balakrishnan K, Luthra R, Keating M, Gandhi V.
    Leuk Lymphoma; 2014 Apr 01; 55(4):876-83. PubMed ID: 23772636
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular cloning of the cDNA for a mutant mouse ribonucleotide reductase M1 that produces a dominant mutator phenotype in mammalian cells.
    Caras IW, Martin DW.
    Mol Cell Biol; 1988 Jul 01; 8(7):2698-704. PubMed ID: 3043191
    [Abstract] [Full Text] [Related]

  • 14. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells.
    Kuo ML, Kinsella TJ.
    Cancer Res; 1998 May 15; 58(10):2245-52. PubMed ID: 9605773
    [Abstract] [Full Text] [Related]

  • 15. Correlation between levels of ferritin and the iron-containing component of ribonucleotide reductase in hydroxyurea-sensitive, -resistant, and -revertant cell lines.
    Hurta RA, Wright JA.
    Biochem Cell Biol; 1991 Sep 15; 69(9):635-42. PubMed ID: 1793565
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
    Yu WJ, Wang YW, Xie ZG, You JF, Wang JL, Cui XL, Pei F, Zheng J.
    Zhonghua Bing Li Xue Za Zhi; 2010 Feb 15; 39(2):88-94. PubMed ID: 20388373
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
    Guo HB, Liu F, Zhao JH, Chen HL.
    J Cell Biochem; 2000 Sep 07; 79(3):370-85. PubMed ID: 10972975
    [Abstract] [Full Text] [Related]

  • 20. Ribonucleotide reductase gene expression during cyclic AMP-induced cell cycle arrest in T lymphocytes.
    Albert DA, Nodzenski E.
    Exp Cell Res; 1992 Dec 07; 203(2):476-82. PubMed ID: 1333983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.